NASDAQ:ATRA
$5.27
(
6.68%
)
Friday, 27th Jan 2023
Atara Biotherapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.85 | $5.30 | Friday, 27th Jan 2023 ATRA stock ended at $5.27. This is 6.68% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 7.51% from a day low at $4.93 to a day high of $5.30. |
| 90 days | $2.83 | $5.61 | |
| 52 weeks | $2.83 | $16.07 |
Historical Atara Biotherapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $4.94 | $5.30 | $4.93 | $5.27 | 781 387 |
| 2023-01-26 | $4.86 | $5.00 | $4.72 | $4.94 | 892 679 |
| 2023-01-25 | $4.68 | $4.86 | $4.51 | $4.82 | 879 612 |
| 2023-01-24 | $4.16 | $4.79 | $4.11 | $4.72 | 1 684 551 |
| 2023-01-23 | $3.90 | $4.18 | $3.80 | $4.16 | 1 189 936 |
| 2023-01-20 | $3.62 | $3.92 | $3.57 | $3.89 | 1 140 000 |
| 2023-01-19 | $3.60 | $3.64 | $3.51 | $3.55 | 784 042 |
| 2023-01-18 | $3.82 | $3.96 | $3.66 | $3.67 | 992 043 |
| 2023-01-17 | $3.99 | $3.99 | $3.75 | $3.78 | 1 452 735 |
| 2023-01-13 | $3.75 | $4.06 | $3.75 | $3.89 | 1 140 671 |
| 2023-01-12 | $3.67 | $3.87 | $3.60 | $3.86 | 1 214 100 |
| 2023-01-11 | $3.62 | $3.70 | $3.52 | $3.66 | 988 800 |
| 2023-01-10 | $3.52 | $3.72 | $3.48 | $3.62 | 943 271 |
| 2023-01-09 | $3.56 | $3.63 | $3.46 | $3.51 | 1 037 600 |
| 2023-01-06 | $3.59 | $3.61 | $3.40 | $3.50 | 1 198 400 |
| 2023-01-05 | $3.41 | $3.57 | $3.36 | $3.56 | 1 488 429 |
| 2023-01-04 | $3.29 | $3.37 | $3.22 | $3.35 | 1 270 244 |
| 2023-01-03 | $3.31 | $3.43 | $3.25 | $3.28 | 1 042 883 |
| 2022-12-30 | $3.11 | $3.28 | $3.06 | $3.28 | 1 564 382 |
| 2022-12-29 | $3.09 | $3.28 | $2.96 | $3.14 | 1 753 288 |
| 2022-12-28 | $2.87 | $3.07 | $2.85 | $2.99 | 1 793 662 |
| 2022-12-27 | $3.05 | $3.06 | $2.83 | $2.85 | 1 637 111 |
| 2022-12-23 | $3.18 | $3.22 | $2.94 | $2.99 | 1 681 019 |
| 2022-12-22 | $3.24 | $3.27 | $2.97 | $3.21 | 2 306 020 |
| 2022-12-21 | $3.66 | $3.67 | $3.28 | $3.31 | 1 577 197 |
| 2022-12-20 | $3.42 | $3.56 | $3.39 | $3.50 | 1 796 734 |
| 2022-12-19 | $3.58 | $3.78 | $3.40 | $3.42 | 3 457 584 |
| 2022-12-16 | $3.51 | $3.62 | $3.27 | $3.52 | 4 440 348 |
| 2022-12-15 | $3.81 | $3.93 | $3.42 | $3.46 | 2 234 634 |
| 2022-12-14 | $4.08 | $4.17 | $3.83 | $3.88 | 1 308 614 |
| 2022-12-13 | $4.49 | $4.49 | $3.96 | $4.10 | 1 998 469 |
| 2022-12-12 | $4.42 | $4.49 | $4.22 | $4.32 | 1 710 244 |
| 2022-12-09 | $4.72 | $4.79 | $4.43 | $4.45 | 1 321 653 |
| 2022-12-08 | $4.76 | $4.77 | $4.42 | $4.74 | 982 961 |
| 2022-12-07 | $4.44 | $4.96 | $4.39 | $4.66 | 1 377 427 |
| 2022-12-06 | $4.65 | $4.67 | $4.36 | $4.48 | 1 489 020 |
| 2022-12-05 | $4.75 | $4.88 | $4.57 | $4.65 | 1 074 309 |
| 2022-12-02 | $4.32 | $4.82 | $4.26 | $4.76 | 751 038 |
| 2022-12-01 | $4.55 | $4.63 | $4.32 | $4.40 | 1 138 228 |
| 2022-11-30 | $4.21 | $4.54 | $4.08 | $4.53 | 1 851 473 |
| 2022-11-29 | $4.08 | $4.18 | $4.00 | $4.17 | 538 014 |
| 2022-11-28 | $4.17 | $4.27 | $4.04 | $4.09 | 752 848 |
| 2022-11-25 | $4.24 | $4.24 | $4.12 | $4.18 | 205 096 |
| 2022-11-23 | $4.22 | $4.47 | $4.16 | $4.17 | 867 005 |
| 2022-11-22 | $4.16 | $4.22 | $4.03 | $4.21 | 690 331 |
| 2022-11-21 | $4.22 | $4.25 | $4.04 | $4.09 | 400 623 |
| 2022-11-18 | $4.40 | $4.45 | $4.18 | $4.22 | 531 889 |
| 2022-11-17 | $4.48 | $4.69 | $4.27 | $4.31 | 994 900 |
| 2022-11-16 | $4.93 | $5.02 | $4.51 | $4.53 | 1 025 134 |
| 2022-11-15 | $5.42 | $5.61 | $4.90 | $5.08 | 726 073 |
About Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
